Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅳ): dose adjustment of anticancer drug in patients with impaired kidney function (Part 1)

Chen Zhe, Zheng Xizi, Zhou Qingqing, Li Guohui

PDF(1034 KB)
PDF(1034 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (8) : 449-453. DOI: 10.3760/cma.j.cn114015‑20240603‑00413

Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅳ): dose adjustment of anticancer drug in patients with impaired kidney function (Part 1)

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(8): 449-453 https://doi.org/10.3760/cma.j.cn114015‑20240603‑00413

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1034 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉